Max Horder, 13, and his sister Mila, 12, have a rare hereditary condition called lysosomal storage disease.
The incurable disease is damaging their bones, affecting both growth and mobility. It is also causing their family financial ruin.

The drug that could offer greater endurance and pain relief is Vimizim but its affordability has placed the family with devastating options.
"We know that it's not a cure but know that it's going to help us a lot," Mila said.
"People who can't walk anymore, they're able to walk now."
The cost of the drug has been estimated to sit at almost half a million dollars per child on an annual basis.